is the most common genetic heart disease but new treatments have meant it is no longer the fatal illness it once was.

, co-director of the Clinic for Hypertrophic Cardiomyopathy and Aortopathies in the Smidt Heart Institute at Cedars-Sinai, is available to discuss current and potential treatments in the pipeline.

 

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Cardiovascular Health Heart Disease Top Hit Stories
KEYWORDS
Cedars-Sinai Hypertrophic Cardiomyopathy Heart Disease Genetic Heart Disorder Smidt Heart Institute Florian Radar, MD